Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review
- First Online:
- 746 Downloads
Interest in non-hormonal therapies for the treatment of menopausal symptoms has increased since the publication of adverse effects of estrogen replacement therapy.
To provide information on the efficacy of non-hormonal therapies for menopausal vasomotor symptoms based on evidence from published randomised controlled studies.
The Cochrane Database of Systematic Reviews (CDSR), MEDLINE, Alternative Therapies in Health and Medicine database (ATHMD) and Allied and Complementary Medicine database (AMED) were searched for randomised controlled trials in the English language reporting data on treatment of menopausal vasomotor symptoms. Trials including cancer breast patients were included.
Our search identified 58 randomised controlled trials of which 11 involved the use of clonidine, six for SSRIs, four for gabapentin, seven for black cohosh, seven for red clover, 18 for phytoestrogens, two for ginseng, one for evening primrose, one for dong quai and one for vitamin E. Most trials had methodological deficiencies.
There is evidence that clonidine, paroxetine, venlafaxine, gabapentin and black cohosh may be beneficial in the treatment of menopausal vasomotor symptoms in some women. Current evidence does not support the use of fluoxetine, red clover, phytoestrogens, Ginseng, evening primrose, dong quai and vitamin E. The side effects profile of these therapies should be considered.
KeywordsMenopause Vasomotor symptoms Hormone replacement therapy Non-hormonal Complimentary Herbal and alternative therapy
- 1.http://www.statistics.gov.uk/populationestimates. Cited 30 Mar 2007)Google Scholar
- 8.Goldberg RM, Loprinzi CL, O’Fallon JR et al (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Clin Oncol 12:155–158Google Scholar
- 9.Pandya KJ, Raubertas RF, Flynn PJ et al (2002) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 132:788–793Google Scholar
- 13.Bolli P, Simpson FO (1975) Clonidine in menopausal flushing: a double blind trial. A N Z Med J 82:1196–1197Google Scholar
- 18.Sadovsky R (2000) Clonidine reduces tamoxifen-induced hot flushes. Am Fam Physician 62(9):2115Google Scholar
- 21.Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB (2005) Management of postmenopausal hot flashes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 105:61–66Google Scholar
- 28.Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA et al (2007) Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. Clin Oncol 25:308–312CrossRefGoogle Scholar
- 33.Newton KM, Reed SD, Grothaus L, Ehrlich K, Guiltinan J, Ludman E, Lacroix AZ (2001) Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19(10):2739–2745Google Scholar
- 34.Verhoeven MO, Van der Mooren MJ, Van de Weijer PH (2005) Effect of a combination of isoflavones and Actaea racemosa Linnaeus on climacteric symptoms in healthy symptomatic perimenopausal women: a 12-week randomized, placebo-controlled, double-blind study. Menopause 12(4):412–420PubMedCrossRefGoogle Scholar
- 38.Jeri AR (2002) The use of an isoflavone supplement to relieve hot flashes. Female patient 27:35–37Google Scholar
- 69.World Health Organization. WHO monographs on selected medicinal plants. Geneva: World Health Organization, 1999Google Scholar